TNF Pharmaceuticals Statistics
Total Valuation
TNFA has a market cap or net worth of $4.01 million. The enterprise value is -$8.61 million.
| Market Cap | 4.01M |
| Enterprise Value | -8.61M |
Important Dates
The last earnings date was Monday, August 19, 2024, before market open.
| Earnings Date | Aug 19, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TNFA has 2.37 million shares outstanding. The number of shares has increased by 44.02% in one year.
| Shares Outstanding | 2.37M |
| Shares Change (YoY) | +44.02% |
| Shares Change (QoQ) | +6.28% |
| Owned by Insiders (%) | 8.36% |
| Owned by Institutions (%) | 3.25% |
| Float | 2.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.48 |
| Quick Ratio | 2.26 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -297.63% and return on invested capital (ROIC) is -139.31%.
| Return on Equity (ROE) | -297.63% |
| Return on Assets (ROA) | -32.43% |
| Return on Capital (ROIC) | -139.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.89M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.28% in the last 52 weeks. The beta is 2.70, so TNFA's price volatility has been higher than the market average.
| Beta (5Y) | 2.70 |
| 52-Week Price Change | -94.28% |
| 50-Day Moving Average | 1.85 |
| 200-Day Moving Average | 3.71 |
| Relative Strength Index (RSI) | 40.95 |
| Average Volume (20 Days) | 60,437 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.40M |
| Pretax Income | -12.29M |
| Net Income | -23.35M |
| EBITDA | n/a |
| EBIT | -13.40M |
| Earnings Per Share (EPS) | -$11.94 |
Balance Sheet
The company has $13.07 million in cash and $25,803 in debt, giving a net cash position of $13.04 million or $5.50 per share.
| Cash & Cash Equivalents | 13.07M |
| Total Debt | 25,803 |
| Net Cash | 13.04M |
| Net Cash Per Share | $5.50 |
| Equity (Book Value) | 382,293 |
| Book Value Per Share | -0.02 |
| Working Capital | 8.57M |
Cash Flow
| Operating Cash Flow | -9.67M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.67M |
| FCF Per Share | -$4.08 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TNFA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -44.02% |
| Shareholder Yield | -44.02% |
| Earnings Yield | -582.91% |
| FCF Yield | -241.38% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 15, 2024. It was a reverse split with a ratio of 0.0333333:1.
| Last Split Date | Feb 15, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0333333:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |